Elon Musk's Neuralink prepares Blindsight implant human trials by 2026, aiming to restore vision for the blind with FDA Breakthrough Device Designation.

Jan 28 (Reuters) - Elon Musk's brain implant company Neuralink said on Wednesday it now has 21 total participants enrolled in ...

Neuralink is preparing to begin its first human clinical trials of the Blindsight implant in 2026, which aims to restore vision for people with complete blindness.Neuralink Founder Elon Musk ...

The neurosurgeon leading the trial tells Sky News the level of control the Neuralink chip offers is "mindblowing" and will be ...

Elon Musk's Neuralink has expanded its human trials to 21 participants and plans to launch a next-generation brain implant with three times the current capabilities later this year, including a future ...

Tech billionaire Elon Musk announced the next-gen Neuralink chips. Plus, first trials for Blindsight augmentation are also on their way.

Neuralink has announced the enrollment of 21 participants in its worldwide clinical trials. This significant milestone marks ...

Elon Musk's Neuralink is ready to conduct its first human implant of a brain device called Blindsight, designed to help ...

Elon Musk's Neuralink is set to release a next-generation cybernetic augment with triple the capability, expected later this year. The company is also preparing its first blindsight augment, which ...

The firm has announced its readiness to implant a new device, Blindsight, into a human patient. The move comes as part of the company's broader mission to develop brain-computer interfaces (BCIs).